Correlation Between Vor Biopharma and Gracell Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Gracell Biotechnologies, you can compare the effects of market volatilities on Vor Biopharma and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Gracell Biotechnologies.
Diversification Opportunities for Vor Biopharma and Gracell Biotechnologies
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vor and Gracell is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Gracell Biotechnologies go up and down completely randomly.
Pair Corralation between Vor Biopharma and Gracell Biotechnologies
If you would invest 73.00 in Vor Biopharma on August 28, 2024 and sell it today you would earn a total of 9.00 from holding Vor Biopharma or generate 12.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Vor Biopharma vs. Gracell Biotechnologies
Performance |
| Timeline |
| Vor Biopharma |
| Gracell Biotechnologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vor Biopharma and Gracell Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vor Biopharma and Gracell Biotechnologies
The main advantage of trading using opposite Vor Biopharma and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.| Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
| Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance |